
GNE-220
CAS No. 1199590-75-4
GNE-220( GNE220 )
Catalog No. M10715 CAS No. 1199590-75-4
GNE-220 is a potent and selective inhibitor of MAP4K4 with IC50 of 7 nM.
Purity : >98% (HPLC)






Size | Price / USD | Stock | Quantity |
5MG | 1143 | Get Quote |
![]() ![]() |
50MG | 2322 | Get Quote |
![]() ![]() |
100MG | 3060 | Get Quote |
![]() ![]() |
200MG | Get Quote | Get Quote |
![]() ![]() |
500MG | Get Quote | Get Quote |
![]() ![]() |
1G | Get Quote | Get Quote |
![]() ![]() |
Biological Information
-
Product NameGNE-220
-
NoteResearch use only, not for human use.
-
Brief DescriptionGNE-220 is a potent and selective inhibitor of MAP4K4 with IC50 of 7 nM.
-
DescriptionGNE-220 is a potent and selective inhibitor of MAP4K4 with IC50 of 7 nM, also inhibits MINK (MAP4K6), DMPK and KHS1 (MAP4K5) with IC50 of 9 nM, 476 nM and 1,110 nM; alters HUVEC sprout morphology, shifts the distribution of subcellular protrusion and increases total protrusions, dose-dependently increases the number of β1-integrin in long focal adhesions.
-
In VitroGNE-220 also inhibits a few other kinases with IC50s of 9nM, 476 nM and 1.1μM for MINK (MAP4K6), DMPK and KHS1 (MAP4K5), respectively. GNE-220 alters human umbilical vein endothelial cells (HUVEC) sprout morphology. GNE-220 also reduces pERM+ retraction fibres in a dose-dependent manner. GNE-220 also dose-dependently increased the number of active-INTβ1+ long focal adhesions (FAs).
-
In Vivo——
-
SynonymsGNE220
-
PathwayMAPK/ERK Signaling
-
TargetMAP4K
-
RecptorMAP4K
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1199590-75-4
-
Formula Weight438.539
-
Molecular FormulaC25H26N8
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESCC1=C2C(=NC(=N1)C3=CN(N=C3)C)C4=C(N2)N=CC(=C4)C5=CC=C(C=C5)N6CCN(CC6)C
-
Chemical Name4-Methyl-8-[4-(4-methyl-1-piperazinyl)phenyl]-2-(1-methyl-1H-pyrazol-4-yl)-5H-pyrido[3',2':4,5]pyrrolo[3,2-d]pyrimidine
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Vitorino P, et al. Nature. 2015 Mar 26;519(7544):425-30.
2. Gao X, et al. Cell Biosci. 2016 Oct 28;6:56. eCollection 2016.
molnova catalog



related products
-
MAP4K4-IN-11e
A potent, selective, ATP-competitive inhibitor of MAP4K4 with IC50 of 1.9 uM.
-
PF 6260933 dihydroch...
PF 6260933 is a potent, selective and orally bioavailable MAP4K4 inhibitor with kinase IC50 of 3.7 nM, cell IC50 of 160 nM.
-
HG6-64-1
HG6-64-1 is a potent dual TAK1 and MAP4K2 ((germinal center kinase, GCK)) inhibitor with IC50 of 41 nM and 98 nM, respectively.